Literature DB >> 8202512

Evidence that inactive p42 mitogen-activated protein kinase and inactive Rsk exist as a heterodimer in vivo.

K M Hsiao1, S Y Chou, S J Shih, J E Ferrell.   

Abstract

Mitogen-activated protein kinases (MAP kinases) are active only when phosphorylated. Here we examine whether the activation of Xenopus p42 MAP kinase might involve changes in its association with other proteins as well as changes in its phosphorylation state. We find that when p42 MAP kinase is phosphorylated and active, it is monomeric, and that when p42 MAP kinase is nonphosphorylated and inactive, about half of it is monomeric and half is a component of a 110-kDa complex. We identify Rsk, an 82-kDa protein kinase that can be phosphorylated and partially activated by p42 MAP kinase, as being specifically associated with inactive p42 MAP kinase. It is possible that the complex of inactive p42 MAP kinase and inactive Rsk acts as a single signal reception particle and that the activation of the two kinases may be better described as a fork in a bifurcating signal transduction pathway than as successive levels in a kinase cascade.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8202512      PMCID: PMC44019          DOI: 10.1073/pnas.91.12.5480

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  In vitro effects on microtubule dynamics of purified Xenopus M phase-activated MAP kinase.

Authors:  Y Gotoh; E Nishida; S Matsuda; N Shiina; H Kosako; K Shiokawa; T Akiyama; K Ohta; H Sakai
Journal:  Nature       Date:  1991-01-17       Impact factor: 49.962

2.  Microtubule-associated protein 2 kinases, ERK1 and ERK2, undergo autophosphorylation on both tyrosine and threonine residues: implications for their mechanism of activation.

Authors:  R Seger; N G Ahn; T G Boulton; G D Yancopoulos; N Panayotatos; E Radziejewska; L Ericsson; R L Bratlien; M H Cobb; E G Krebs
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

3.  Cell cycle tyrosine phosphorylation of p34cdc2 and a microtubule-associated protein kinase homolog in Xenopus oocytes and eggs.

Authors:  J E Ferrell; M Wu; J C Gerhart; G S Martin
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

4.  Mouse Erk-1 gene product is a serine/threonine protein kinase that has the potential to phosphorylate tyrosine.

Authors:  C M Crews; A A Alessandrini; R L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

5.  Characterization of insulin-stimulated microtubule-associated protein kinase. Rapid isolation and stabilization of a novel serine/threonine kinase from 3T3-L1 cells.

Authors:  L B Ray; T W Sturgill
Journal:  J Biol Chem       Date:  1988-09-05       Impact factor: 5.157

6.  Tyrosine phosphorylation and activation of homologous protein kinases during oocyte maturation and mitogenic activation of fibroblasts.

Authors:  J Posada; J Sanghera; S Pelech; R Aebersold; J A Cooper
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

7.  Cyclin activation of p34cdc2.

Authors:  M J Solomon; M Glotzer; T H Lee; M Philippe; M W Kirschner
Journal:  Cell       Date:  1990-11-30       Impact factor: 41.582

8.  Purification and properties of extracellular signal-regulated kinase 1, an insulin-stimulated microtubule-associated protein 2 kinase.

Authors:  T G Boulton; J S Gregory; M H Cobb
Journal:  Biochemistry       Date:  1991-01-08       Impact factor: 3.162

9.  Mos induces the in vitro activation of mitogen-activated protein kinases in lysates of frog oocytes and mammalian somatic cells.

Authors:  E K Shibuya; J V Ruderman
Journal:  Mol Biol Cell       Date:  1993-08       Impact factor: 4.138

10.  Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase).

Authors:  D M Payne; A J Rossomando; P Martino; A K Erickson; J H Her; J Shabanowitz; D F Hunt; M J Weber; T W Sturgill
Journal:  EMBO J       Date:  1991-04       Impact factor: 11.598

View more
  25 in total

1.  Distinct, constitutively active MAPK phosphatases function in Xenopus oocytes: implications for p42 MAPK regulation In vivo.

Authors:  M L Sohaskey; J E Ferrell
Journal:  Mol Biol Cell       Date:  1999-11       Impact factor: 4.138

2.  Characterization of Fus3 localization: active Fus3 localizes in complexes of varying size and specific activity.

Authors:  K Y Choi; J E Kranz; S K Mahanty; K S Park; E A Elion
Journal:  Mol Biol Cell       Date:  1999-05       Impact factor: 4.138

Review 3.  ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions.

Authors:  Philippe P Roux; John Blenis
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

Review 4.  Insulin signal transduction through protein kinase cascades.

Authors:  J Avruch
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

5.  A link between MAP kinase and p34(cdc2)/cyclin B during oocyte maturation: p90(rsk) phosphorylates and inactivates the p34(cdc2) inhibitory kinase Myt1.

Authors:  A Palmer; A C Gavin; A R Nebreda
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

6.  Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity.

Authors:  Philippe P Roux; Stephanie A Richards; John Blenis
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

7.  Dependence of Mos-induced Cdc2 activation on MAP kinase function in a cell-free system.

Authors:  C Y Huang; J E Ferrell
Journal:  EMBO J       Date:  1996-05-01       Impact factor: 11.598

8.  Evidence for two catalytically active kinase domains in pp90rsk.

Authors:  T L Fisher; J Blenis
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

9.  Induction of a G2-phase arrest in Xenopus egg extracts by activation of p42 mitogen-activated protein kinase.

Authors:  S A Walter; T M Guadagno; J E Ferrell
Journal:  Mol Biol Cell       Date:  1997-11       Impact factor: 4.138

10.  Minimizing off-target effects by using diced siRNAs for RNA interference.

Authors:  Jason W Myers; Jen-Tsan Chi; Delquin Gong; Marci E Schaner; Patrick O Brown; James E Ferrell
Journal:  J RNAi Gene Silencing       Date:  2006-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.